These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 9200473)
1. Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer. Chen L; Chen D; Block E; O'Donnell M; Kufe DW; Clinton SK J Immunol; 1997 Jul; 159(1):351-9. PubMed ID: 9200473 [TBL] [Abstract][Full Text] [Related]
2. Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12. Gambotto A; Tüting T; McVey DL; Kovesdi I; Tahara H; Lotze MT; Robbins PD Cancer Gene Ther; 1999; 6(1):45-53. PubMed ID: 10078963 [TBL] [Abstract][Full Text] [Related]
3. [Construction of a RU486 inducible recombinant adenoviral vector carrying murine interleukin-12 gene and experimental treatment of colonic carcinoma]. Chen J; Liu XS; Wang F; Xue XC; Fang GE; Su CQ; Qian QJ Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1372-6. PubMed ID: 19671324 [TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity. Slos P; De Meyer M; Leroy P; Rousseau C; Acres B Cancer Gene Ther; 2001 May; 8(5):321-32. PubMed ID: 11477452 [TBL] [Abstract][Full Text] [Related]
5. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. Tahara H; Zitvogel L; Storkus WJ; Zeh HJ; McKinney TG; Schreiber RD; Gubler U; Robbins PD; Lotze MT J Immunol; 1995 Jun; 154(12):6466-74. PubMed ID: 7759882 [TBL] [Abstract][Full Text] [Related]
6. Regional treatment of hepatic micrometastasis by adenovirus vector-mediated delivery of interleukin-2 and interleukin-12 cDNAs to the hepatic parenchyma. Hirschowitz EA; Naama HA; Evoy D; Lieberman MD; Daly J; Crystal RG Cancer Gene Ther; 1999; 6(6):491-8. PubMed ID: 10608345 [TBL] [Abstract][Full Text] [Related]
7. Transmissibility of murine stem cell virus-based retroviral vectors carrying both interleukin-12 cDNAs and a third gene: implications for immune gene therapy. Lieu FH; Hawley TS; Fong AZ; Hawley RG Cancer Gene Ther; 1997; 4(3):167-75. PubMed ID: 9171935 [TBL] [Abstract][Full Text] [Related]
8. Effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12. Yamazaki M; Zhang R; Straus FH; Messina M; Robinson BG; Hashizume K; DeGroot LJ Gene Ther; 2002 Jan; 9(1):64-74. PubMed ID: 11850724 [TBL] [Abstract][Full Text] [Related]
9. In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity. Toda M; Martuza RL; Kojima H; Rabkin SD J Immunol; 1998 May; 160(9):4457-64. PubMed ID: 9574551 [TBL] [Abstract][Full Text] [Related]
10. Construction of a recombinant adeno-associated virus (rAAV) vector expressing murine interleukin-12 (IL-12). Paul D; Qazilbash MH; Song K; Xu H; Sinha BK; Liu J; Cowan KH Cancer Gene Ther; 2000 Feb; 7(2):308-15. PubMed ID: 10770641 [TBL] [Abstract][Full Text] [Related]
11. Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity. Odaka M; Sterman DH; Wiewrodt R; Zhang Y; Kiefer M; Amin KM; Gao GP; Wilson JM; Barsoum J; Kaiser LR; Albelda SM Cancer Res; 2001 Aug; 61(16):6201-12. PubMed ID: 11507073 [TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer. Tahara H; Lotze MT Gene Ther; 1995 Mar; 2(2):96-106. PubMed ID: 7719935 [TBL] [Abstract][Full Text] [Related]
13. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity. Guo J; Wang B; Zhang M; Chen T; Yu Y; Regulier E; Homann HE; Qin Z; Ju DW; Cao X Gene Ther; 2002 Jun; 9(12):793-803. PubMed ID: 12040461 [TBL] [Abstract][Full Text] [Related]
14. Intratumor murine interleukin-12 gene therapy suppressed the growth of local and distant Ewing's sarcoma. Jia SF; Duan X; Worth LL; Guan H; Kleinerman ES Cancer Gene Ther; 2006 Oct; 13(10):948-57. PubMed ID: 16763609 [TBL] [Abstract][Full Text] [Related]
15. [Gene transfer of murine Flt3 ligand mediated by adenoviral vector efficiently induces growth inhibition of murine liver cancer]. Yang Q; Yang G; Wei L; Jia F; Wu M; Guo Y Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):775-9. PubMed ID: 12126551 [TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity. Hwang KS; Cho WK; Yoo J; Seong YR; Kim BK; Kim S; Im DS Cancer Gene Ther; 2004 Jun; 11(6):397-407. PubMed ID: 15044962 [TBL] [Abstract][Full Text] [Related]
17. AdCD40L gene therapy counteracts T regulatory cells and cures aggressive tumors in an orthotopic bladder cancer model. Loskog AS; Fransson ME; Totterman TT Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8816-21. PubMed ID: 16361570 [TBL] [Abstract][Full Text] [Related]
18. Tumor irradiation followed by intratumoral cytokine gene therapy for murine renal adenocarcinoma. Hillman GG; Slos P; Wang Y; Wright JL; Layer A; De Meyer M; Yudelev M; Che M; Forman JD Cancer Gene Ther; 2004 Jan; 11(1):61-72. PubMed ID: 14681727 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis. Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141 [TBL] [Abstract][Full Text] [Related]
20. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer. Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]